Institutional Ownership Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX). We have compiled data on the 197 institutions that hold shares in the stock, with a total of 69.7 Million shares, which have been reported (via 13F filing form) to have a value of $1.39 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
597,605
shares
|
$11.9 Million
0.0% of portfolio
|
Q4 2024
Added 6.2%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
544,330
shares
|
$10.9 Million
0.0% of portfolio
|
Q4 2024
Added 1.02%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
518,340
shares
|
$10.3 Million
0.01% of portfolio
|
Q4 2024
Reduced 37.18%
|
|
|
5 Am Venture Management, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
497,270
shares
|
$9.92 Million
5.58% of portfolio
|
Q4 2023
Added 60.27%
|
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Feb 14, 2025 Q4 2024 |
474,103
shares
|
$9.46 Million
2.47% of portfolio
|
Q4 2024
Added 13.12%
|
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Feb 05, 2025 Q4 2024 |
452,497
shares
|
$9.03 Million
0.0% of portfolio
|
Q4 2024
Added 20.87%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
389,797
shares
|
$7.78 Million
0.0% of portfolio
|
Q4 2024
Added 133.98%
|
|
|
Vestal Point Capital, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
305,000
shares
|
$6.08 Million
0.46% of portfolio
|
Q4 2024
New holding
|
|
|
Crestline Management, LP
Fort Worth, TX |
Feb 13, 2025 Q4 2024 |
295,354
shares
|
$5.89 Million
0.26% of portfolio
|
Q4 2024
Added 114.04%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
288,378
shares
|
$5.75 Million
0.0% of portfolio
|
Q4 2024
Reduced 20.7%
|
|
|
Silverarc Capital Management, LLC
|
Feb 14, 2025 Q4 2024 |
264,560
shares
|
$5.28 Million
1.61% of portfolio
|
Q4 2024
Added 82.46%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
247,644
shares
|
$4.94 Million
0.07% of portfolio
|
Q4 2023
New holding
|
|
|
Tsp Capital Management Group, LLC
|
Jan 30, 2025 Q4 2024 |
223,343
shares
|
$4.46 Million
2.14% of portfolio
|
Q4 2024
Reduced 9.88%
|
|
|
Tfg Asset Management Gp LTD
Grand Cayman, E9 |
Feb 21, 2025 Q4 2024 |
192,000
shares
|
$3.83 Million
1.59% of portfolio
|
Q4 2024
New holding
|
|
|
Axa S.A.
Paris, I0 |
Feb 14, 2025 Q4 2024 |
185,040
shares
|
$3.69 Million
0.01% of portfolio
|
Q2 2024
Reduced 23.1%
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Feb 14, 2025 Q4 2024 |
154,512
shares
|
$3.08 Million
0.03% of portfolio
|
Q4 2024
New holding
|
|
|
Rafferty Asset Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
152,454
shares
|
$3.04 Million
0.01% of portfolio
|
Q4 2024
Added 67.55%
|
|
|
Td Asset Management Inc
|
Feb 11, 2025 Q4 2024 |
143,878
shares
|
$2.87 Million
0.0% of portfolio
|
Q4 2024
Reduced 12.31%
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
142,914
shares
|
$2.85 Million
0.0% of portfolio
|
Q4 2024
Added 9.61%
|
|
|
Readystate Asset Management LP
Chicago, IL |
Feb 14, 2025 Q4 2024 |
142,038
shares
|
$2.83 Million
0.11% of portfolio
|
Q4 2024
Reduced 20.88%
|
|
|
Polar Asset Management Partners Inc.
Toronto, A6 |
Feb 25, 2025 Q4 2024 |
137,550
shares
|
$2.74 Million
0.06% of portfolio
|
Q4 2024
Added 1318.04%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
136,588
shares
|
$2.72 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
121,501
shares
|
$2.42 Million
0.0% of portfolio
|
Q4 2024
Added 207.92%
|
|
|
Mirador Capital Partners LP
|
Jan 14, 2025 Q4 2024 |
119,492
shares
|
$2.38 Million
0.57% of portfolio
|
Q4 2024
Added 2.88%
|
|
|
Citigroup Inc
|
Feb 12, 2025 Q4 2024 |
119,359
shares
|
$2.38 Million
0.0% of portfolio
|
Q4 2024
Added 135.28%
|